Isotretinoin Capsule
Product Images NDC 0591-2451

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 0591-2451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of isotretinoin, showing its molecular configuration with multiple double bonds and functional groups, as depicted in a skeletal formula diagram.*

FDA Label Image

1 (Image 2)

A line graph displaying mean lesion count over time (baseline to week 20) during analysis visits. Two lines compare Isotretinoin capsules and Isotretinoin (unspecified), both showing a gradual decrease in lesion count from baseline around 20 to below 5 by week 20.*

FDA Label Image

1 (Image 3)

Isotretinoin Capsules, USP 10 mg oral capsules packaging label from Teva Pharmaceuticals. The label states each capsule contains 10 mg isotretinoin and comes in a 30 capsule supply divided into 3 packs of 10. The label includes warnings about birth defects and instructs pharmacists to dispense with an enclosed medication guide. The product is Rx only and manufactured by Teva Pharma, Inc.*

FDA Label Image

1 (Image 4)

Packaging label for Isotretinoin Capsules USP 20 mg by Actavis Pharma, Inc. The box contains 30 capsules in three prescription packs of 10 capsules each. The label includes warnings about birth defects and instructions for pharmacists to dispense with an enclosed medication guide. The labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

1 (Image 5)

Isotretinoin Capsules, USP 25 mg oral capsules packaging label from Actavis Pharma, Inc. The label indicates each capsule contains 25 mg isotretinoin, with a total of 30 capsules (3 x 10 prescription packs). The label highlights warnings including birth defect risks and instructions to dispense with an enclosed Medication Guide.*

FDA Label Image

1 (Image 6)

Isotretinoin Capsules, USP 30 mg oral capsules in a 30-count package (3 x 10 prescription packs) from Actavis Pharma, Inc. The label emphasizes dispensing with an enclosed medication guide and includes warnings about birth defects and pregnancy prevention. The label shows the NDC 0591-2435-15 and manufacturing information by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

1 (Image 7)

Isotretinoin Capsules, USP 35 mg oral capsules packaging label by Actavis Pharma, Inc. The box contains 30 capsules in (3 x 10) prescription packs. The label includes warnings about birth defects and advises pharmacists to dispense only with the enclosed Medication Guide. The packaging emphasizes the importance of not dispensing to pregnant patients and includes instructions for pharmacists regarding patient authorization programs.*

FDA Label Image

1 (Image 8)

Packaging label for Isotretinoin Capsules, USP 40 mg by Actavis Pharma, Inc., a human prescription oral capsule. The label states each capsule contains 40 mg isotretinoin and comes in a carton of 30 capsules (3 x 10 prescription packs). It includes warnings about birth defects and instructions to dispense with a medication guide. The label also features the Teva logo and instructions for pharmacists.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.